Hidradenitis Suppurativa: Managing a Complex Disease with Multiple Comorbidities

Authors

Susan K. Smith M.S., PA-C, University of LynchburgFollow

Specialty

Dermatology

Advisor

Dr. Elyse Watkins DHSc, PA-C, NCMP, DFAAPA

Abstract

ABSTRACT

Hidradenitis suppurativa (HS) is an inflammatory disease that is recurrent of the subcutaneous tissue and skin that consists of inflamed nodules and deep abscesses that may eventually lead to draining sinus tracts and widespread scarring. Associated symptoms of HS can often be incapacitating, so early diagnosis is imperative. HS frequently develops during adolescence or early adulthood. HS does occur more often in females and African Americans, and one-third of patients have a family member who also has HS. This article outlines an overview of how the latest update on the pathophysiology of HS has had an impact on the effective treatment options and management suggestions and discusses the potential comorbidities of HS that can affect the general health of these patients.

Although the entire pathophysiology of HS is still not completely understood, ongoing research is leading to more effective management approaches. This article is intended to review the most common and efficacious treatment guidelines that have evidence-based clinical findings with statistical significance in the present literature. Comorbidity screening is essential, and the dermatology provider needs to advocate for the HS patient and manage referrals when necessary. Understanding the stages of HS, the treatments available, and how to manage patients for both the short and long terms are the key to improved patient satisfaction and management.

Recommended Citation

Smith SK. Hidradenitis Suppurativa: Managing a Complex Disease with Multiple Comorbidities. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2022; 4(2).